CAS 16846-24-5
:Josamycin
Description:
Josamycin is a macrolide antibiotic that is primarily derived from the fermentation of the bacterium Streptomyces narbonensis. It is characterized by its ability to inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby preventing the growth of susceptible bacteria. Josamycin exhibits a broad spectrum of activity against various Gram-positive bacteria and some Gram-negative organisms, making it effective in treating respiratory tract infections, skin infections, and certain sexually transmitted diseases. The compound is typically administered orally and is known for its favorable pharmacokinetic properties, including good tissue penetration and a relatively long half-life. Josamycin is also notable for its low toxicity profile, which contributes to its therapeutic use. However, like other antibiotics, it can lead to the development of antibiotic resistance if misused. Its chemical structure includes a large lactone ring, which is a common feature of macrolide antibiotics, contributing to its biological activity and stability.
Formula:C42H69NO15
InChI:InChI=1/C42H69NO15/c1-23(2)19-32(47)56-40-27(6)53-34(22-42(40,8)50)57-37-26(5)54-41(36(49)35(37)43(9)10)58-38-29(17-18-44)20-24(3)30(46)16-14-12-13-15-25(4)52-33(48)21-31(39(38)51-11)55-28(7)45/h12-14,16,18,23-27,29-31,34-41,46,49-50H,15,17,19-22H2,1-11H3/b13-12+,16-14+/t24-,25-,26?,27?,29+,30+,31-,34?,35?,36?,37?,38+,39+,40?,41?,42?/m1/s1
InChI key:InChIKey=XJSFLOJWULLJQS-NGVXBBESSA-N
SMILES:O([C@@H]1[C@@H](OC)[C@H](OC(C)=O)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@@H]1CC=O)[C@H]2[C@H](O)[C@@H](N(C)C)[C@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(CC(C)C)=O)[C@H](C)O3)[C@@H](C)O2
Synonyms:- (2S,3R,4R,6S)-6-{[(2R,3S,4R,5R,6S)-6-{[(4R,6S,7R,9R,10R,11E,13E,16R)-4-(acetyloxy)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)oxacyclohexadeca-11,13-dien-6-yl]oxy}-4-(dimethylamino)-5-hydroxy-2-methyltetrahydro-2H-pyran-3-yl]oxy}-4-hydroxy-2,4-dimethyltetrahydro-2H-pyran-3-yl 3-methylbutanoate (non-preferred name)
- (2S,3S,4R,6S)-6-{[(2R,3S,4R,5R,6S)-6-{[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-(acetyloxy)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)oxacyclohexadeca-11,13-dien-6-yl]oxy}-4-(dimethylamino)-5-hydroxy-2-methyltetrahydro-2H-pyran-3-yl]oxy}-4-hydroxy-2,4-dimethyltetrahydro-2H-pyran-3-yl 3-methylbutanoate (non-preferred name)
- 6-{[6-{[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-(acetyloxy)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)oxacyclohexadeca-11,13-dien-6-yl]oxy}-4-(dimethylamino)-5-hydroxy-2-methyltetrahydro-2H-pyran-3-yl]oxy}-4-hydroxy-2,4-dimethyltetrahydro-2H-pyran-3-yl 3-methylbutanoate (non-preferred name)
- Antibiotic YL 704A3
- Antibiotic YL 704A<sub>3</sub>
- En 141
- Iosalide
- Jomybel
- Josacine
- Josamicina
- Josamina
- Josamycin solution
- Josamycine
- Kitasamycin A3
- Kitasamycin A<sub>3</sub>
- Leucomycin A3
- Leucomycin A<sub>3</sub>
- Leucomycin V, 3-acetate 4<sup>B</sup>-(3-methylbutanoate)
- Leucomycin V, 3-acetate 4B-(3-methylbutanoate)
- Oxacyclohexadecane, leucomycin V deriv.
- Turimycin A5
- Turimycin A<sub>5</sub>
- Vilprafen
- Wilprafen
- JOSAMYCIN
- turimycina5
- 3-acetate4(supb)-(3-methylbutanoate)
- Leucomycin A3 (>90%)
- [(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxa
- (4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-(acetyloxy)-6-[[3,6-dideoxy-4-O-[2,6-dideoxy-3-C-methyl-4-O-(3-methylbutanoyl)-α-L-ribo-hexopyranosyl]-3-(dimethylamino)-β-D-glucopyranosyl]oxy]-10-hydroxy-5-methoxy-9,16-dimethyl-7-(2-oxoethyl)oxacyclohexadeca-11,13-dien-2-one (josamycin)
- LEUCOMYCIN V,3-AC-ETA 4B-(3-METHYLBUTANOATE)
- C12662
- (2S,3S,4R,6S)-6-(((2R,3S,4R,5R,6S)-6-(((4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-Acetoxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)oxacyclohexadeca-11,13-dien-6-yl)oxy)-4-(dimethylamino)-5-hydroxy-2-methyltetrahydro-2H-pyran-3-yl)oxy)-4-hydroxy-2,4-
- Josamycin Standard
- 3-Acetate 4B-(3-Methylbutanoate)leucoMycin V
- JOSAMYCIN(16846-24-5)
- Leucomycin V, 3-acetate 4B-(3-methylbutanoate) (9CI)
- LEUCOMYCIN V,3-ACETA 4BETA-(3-METHYL BUTANOATE)
- kitasamycina3
- Josamycin for peak identification CRS
- antibioticyl-704a3
- JOSAMYCIN USP/EP/BP
- lucamycin
- LEUCOMYCIN V,3-ACETA 4β-(3-METHYL BUTANOATE)
- Josamycin Solution, 100ppm
- YL-704A3
- Leucomycin A3 (8CI)
- Leucomycin V 3-acetate 4''-(3-methylbutanoate)
- Pre-validation
- Josamycin for peak identification
- leucomycinv,3-acetate4(supb)-(3-methylbutanoate)
- Josamycin CRS
- Sparsentan Impurity 65
- Josamycin solution solution,1000ppm
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 16 products.
Josamycin, 98%
CAS:<p>Macrolide antibiotic</p>Formula:C42H69NO15Purity:98%Color and Shape:White, PowderMolecular weight:827.99JOSAMYCIN FOR PEAK IDENTIFICATION CRS
CAS:JOSAMYCIN FOR PEAK IDENTIFICATION CRSFormula:C42H69NO15Molecular weight:827.995Leucomycin V, 3-acetate 4B-(3-methylbutanoate)
CAS:Formula:C42H69NO15Purity:95%Color and Shape:SolidMolecular weight:827.9950(2S,3S,4R,6S)-6-(((2R,3S,4R,5R,6S)-6-(((4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-Acetoxy-10-Hydroxy-5-Methoxy-9,16-Dimethyl-2-Oxo-7-(2-Oxoethyl)Oxacyclohexadeca-11,13-Dien-6-Yl)Oxy)-4-(Dimethylamino)-5-Hydro
CAS:(2S,3S,4R,6S)-6-(((2R,3S,4R,5R,6S)-6-(((4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-Acetoxy-10-Hydroxy-5-Methoxy-9,16-Dimethyl-2-Oxo-7-(2-Oxoethyl)Oxacyclohexadeca-11,13-Dien-6-Yl)Oxy)-4-(Dimethylamino)-5-HydroPurity:98%Molecular weight:828g/molJosamycin 1000 µg/mL in Acetonitrile
CAS:Controlled ProductFormula:C42H69NO15Color and Shape:Single SolutionMolecular weight:828.00GB 31660.1-2019 Macrolide Antibiotics Mixture 167 100 µg/mL in Methanol
CAS:Controlled ProductColor and Shape:MixtureJOSAMYCIN
CAS:Josamycin (EN-141) is a macrolide antibiotic exhibiting antimicrobial activity. The dissociation constant Kd from ribosome for Josamycin is 5.5 nM.Formula:C42H69NO15Purity:91.38% - 99.88%Color and Shape:SolidMolecular weight:827.99Leucomycin A3
CAS:<p>Applications A 16-membered ring macrolide antibiotic with antimicrobial activity against a wide range of pathogens. Particularly used in the treatment of Mycoplasma infection.<br>References Osono, T. et al.: J. Antibiot., 27, 366 (1974); Kuriaki, K. et al.: Jpn. J. Antibiot., 22, 232 (1969); Tan K. et al.: Zhonghua Yiyuamganranxue Zazhi, 16, 235 (2006);<br></p>Formula:C42H69NO15Purity:>90%Color and Shape:NeatMolecular weight:828.00Leucomycin A3
CAS:<p>Leucomycin A3 is a macrolide antibiotic with a mode of action that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. It is used for treating bacterial infections and has shown potential antiviral activity.</p>Formula:C42H69NO15Purity:Min. 95%Color and Shape:White PowderMolecular weight:828 g/molJosamycin 10 µg/mL in Acetonitrile
CAS:Formula:C42H69NO15Color and Shape:Colourless LiquidMolecular weight:828.00











